SG Americas Securities
COLL icon

SG Americas Securities’s Collegium Pharmaceutical COLL Stock Holding History

SG Americas Securities’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Sell
3,233
-63,164
-95% -$2.16M ﹤0.01% 3042
2026
Q1 		$2.2M Buy
66,397
+49,123
+284% +$2.08M ﹤0.01% 1354
2025
Q4 		$800K Sell
17,274
-11,704
-40% -$490K ﹤0.01% 2189
2025
Q3 		$1.01M Buy
28,978
+19,796
+216% +$688K ﹤0.01% 1443
2025
Q2 		$272K Sell
9,182
-5,095
-36% -$145K ﹤0.01% 2080
2025
Q1 		$426K Buy
14,277
+578
+4% +$17.7K ﹤0.01% 1901
2024
Q4 		$392K Sell
13,699
-4,586
-25% -$152K ﹤0.01% 1558
2024
Q3 		$707K Buy
18,285
+1,470
+9% +$52.4K ﹤0.01% 1378
2024
Q2 		$541K Buy
16,815
+2,785
+20% +$96.6K ﹤0.01% 1642
2024
Q1 		$545K Sell
14,030
-4,214
-23% -$147K ﹤0.01% 1384
2023
Q4 		$562K Buy
18,244
+8,339
+84% +$209K 0.01% 1403
2023
Q3 		$221K Buy
+9,905
New +$226K ﹤0.01% 2259
2023
Q2 		– Sell
-24,472
Closed -$587K – 2442
2023
Q1 		$587K Buy
+24,472
New +$649K 0.01% 1594
2022
Q3 		– Sell
-7,404
Closed -$131K – 3235
2022
Q2 		$131K Sell
7,404
-9,883
-57% -$166K ﹤0.01% 2951
2022
Q1 		$352K Sell
17,287
-15,698
-48% -$297K ﹤0.01% 2105
2021
Q4 		$616K Sell
32,985
-5,756
-15% -$112K ﹤0.01% 2011
2021
Q3 		$765K Buy
+38,741
New +$838K ﹤0.01% 2132
2021
Q2 		– Sell
-9,918
Closed -$235K – 2906
2021
Q1 		$235K Buy
+9,918
New +$236K ﹤0.01% 2566
2020
Q3 		– Sell
-20,494
Closed -$359K – 2828
2020
Q2 		$359K Buy
20,494
+8,448
+70% +$165K ﹤0.01% 2385
2020
Q1 		$197K Buy
12,046
+5,990
+99% +$124K ﹤0.01% 2515
2019
Q4 		$125K Buy
+6,056
New +$101K ﹤0.01% 2817
2017
Q1 		– Sell
-9,891
Closed -$154K – 3304
2016
Q4 		$154K Buy
+9,891
New +$164K ﹤0.01% 2553

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

SG Americas Securities's COLL Position: Q2 2026 in Review

SG Americas Securities reduced its Collegium Pharmaceutical (COLL) stake by 95% in Q2 2026, selling an estimated $2.16M and leaving 3,233 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #3042.

SG Americas Securities first reported a position in COLL in Q4 2016 and has held it in 22 quarters since. The position peaked at $2.2M in Q1 2026. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • SG Americas Securities held 3,233 shares of Collegium Pharmaceutical worth $117K as of Q2 2026.
  • SG Americas Securities sold 63,164 Collegium Pharmaceutical shares in Q2 2026, an estimated $2.16M.
  • Collegium Pharmaceutical made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3042 holding.
  • SG Americas Securities first reported a position in Collegium Pharmaceutical in Q4 2016 and has held it in 22 quarters since.
  • SG Americas Securities's Collegium Pharmaceutical position peaked at $2.2M in Q1 2026.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.